CTLA4 (CD152) modulates the Th subset response and alters the course of experimental Leishmania major infection

European Journal of Immunology

Volumn 28, Issue 12, 1998, Pages 4213-4220

  Saha, Bhaskar ^a,b   Chattopadhyay, Suchismita ^a   Germond, Rhonda ^a   Harlan, David M ^a   Perrin, Peter James ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

CD152; Leishmaniasis; Th subset differentiation

Indexed keywords

ANTIBODY; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; KEYHOLE LIMPET HEMOCYANIN; PARASITE ANTIGEN; PICRIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; FEMALE; GENETIC SUSCEPTIBILITY; HELPER CELL; LEISHMANIA MAJOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN LEISHMANIASIS; T LYMPHOCYTE ACTIVATION;

EID: 0031739697     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199812)28:12<4213::AID-IMMU4213>3.0.CO;2-C     Document Type: Article

References (38)

1. Blackwell, J. M., Genetic susceptibility to leishmania infection: studies on mice and man. Parasitology 1996. 112: S67-S74.
2. Liew, F. Y. and O'Donnell, C. A., Immunology of Leishmaniasis. Adv. Parasitol. 1993. 32: 161-259.
3. Reiner, S. and Locksley, R. M., The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 1995. 13: 151-177.
4. Mossman, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 2348-2357.
5. Cherwinski, H., Schumacher, J. H., Brown, K. D. and Mossman, T. R., Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 1987. 166: 1229-1244.
6. Martin, E. C., Nathan, C. and Xie, Q., Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. Med. 1994. 180: 977-984.
7. Green, S., Scheller, M., Marletta, M., Seguin, M., Klotz, F., Slayter, M., Nelson, B. and Nacy, C. A., Nitric oxide: cytokine regulation of nitric oxide in host resistance to intracellular pathogens, Immunol. Lett. 1994. 43: 87-94.
8. Fiorentino, D. F., Bond, M. W. and Mossman, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 2081-2089.
9. Wenner, C. A., Guler, M. L., Macatonia, S. E., O'Garra, A. and Murphy, K. M., Roles of IFN-gamma and IFN-alpha in IL-12 induced T helper cell-1 development. J. Immunol. 1996. 156: 1442-1447.
10. + T cells. J. Exp. Med. 1997. 185: 461-469.
11. Bach, E. A., Szabo, S. Z., Dighe, A. S., Ashkenazi, A., Aguet, M., Murphy, K. M. and Schreiber, R. D., ligand-induced autor-regulation of IFN-gamma receptor beta chain expression in T helper cell subsets. Science 1995. 270: 1215-1218.
12. Szabo, S. Z., Dighe, A. S., Gubler, U. and Murphy, K. M., Regulation of the interleukin(IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997. 185: 817-824.
13. Doherty, T. M. and Coffman, R. L., Leishmania antigens presented by GM-CSF derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 1993. 150: 5476-5483.
14. Lee, K. C. and Wong, M., Functional heterogeneity of culture grown bone marrow-derived macrophages. II. Lymphokine stimulation of antigen-presenting function. J. Immunol. 1982. 128: 2487-2494.
15. Hosken, N. A., Shibuya, K., Heath, A. W., Murphy, K. M. and O'Garra, A., The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model. J. Exp. Med. 1995. 182: 1579-1584.
16. Bretscher, P. A., Wei, G., Menon, J. N. and Bielefeldt Ohmann, H., Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science 1992. 257: 539-541.
17. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 1994. 15: 321-331.
18. Harding, F. A., McArthur, J. G., Gross, J. A., Raulet, D. A. and Allison, J. P., CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T cell clones. Nature 1992. 356: 607-609.
19. Boussiotis, V. A., Freeman, G. J., Berezovskaya, A., Barber, D. L. and Nadler, L. M., Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap-1. Science 1997. 278: 124-126.
20. Murphy, M. L., Engwerda, C. R., Gorak, P. M. A. and Kaye, P. M., B7-2 blockade enhanced T cell responses to Leishmania donovani. J. Immunol. 1997. 159: 4460-4466.
21. Saha, B., Das, G., Vohra, H., Ganguly, N. K. and Mishra, G. C., Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity. Eur. J. Immunol. 1995. 25: 2492-2498.
22. Kaye, P. M., Rogers, N. J., Curry, A. J. and Scott, J. C., Deficient expression of costimulatory molecules on Leishmania-infected macrophages. Eur. J. Immunol. 1994. 24: 2850-2855.
23. Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M., Ledbetter, J., Singh, C. and Tepper, M., Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992. 257: 792-795.
24. Corry, D., Reiner, S. L., Linsley, P. S. and Locksley, R. M., Differential blockade of CD28-B7 on the development of Th1 and Th2 effector cells in experimental leishmaniasis. J. Immunol. 1994. 153: 4142-4148.
25. Brown, D. R., Green, J. M., Moskowitz, N. H., Davis, M., Thompson, C. B. and Reiner, S. L., Limited role of CD28-mediated signals in T helper subset differentiation. J. Exp. Med. 1996. 184: 803-810.
26. Walunas, T. L., Bakker, C. Y. and Bluestone, J. A., CTLA4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 1996. 183: 2541-2550.
27. Perrin, P. J., Maldonado, J. H., Davis, T. A., June, C. H. and Racke, M. K., CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis. J. Immunol 1996. 157: 1333-1335.
28. Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B. and Allison, J. P., Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA 1997. 94: 8099-8103.
29. Leach, D. R., Krummel, M. F. and Allison, J. P., Enhancement of anti-tumor immunity by CTLA-4 block-ade. Science 1996. 271: 1734-1736.
30. Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Tompson, C. B., Griesser, H. and Mak, T. W., Lymphoproliferative disorders with early lethality in mice deficient in CTLA4. Science 1995. 270: 985-989.
31. Wu, Y., Quo, Y., Huang, A., Zheng, P. and Liu, Y., CTLA4-B7 interaction is sufficient to costimulate T cell clonal expansion. J. Exp. Med. 1997. 185: 1327-1335.
32. Damle, N. K., Klussman, K., Leytze, G., Myrdal, S., Aruffo, A., Ledbetter, J. A. and Linsley, P. S., Costimulation of T lymphocytes with integrin ligands ICAM-1 or VCAM-1 induces functional expression of CTLA4, a second receptor for B7. J. Immunol. 1994. 152: 2686-2697.
33. Basak, S. K., Saha, B., Bhattacharrya, A. and Roy, S., Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed type hypersensitivity response and up-regulation of B cell activation. Eur. J. Immunol. 1992. 22: 2041-2045.
34. Launois, P., Maillard, I., Pingel, S., Swihart, K. G., Xenarios, I., Acha-Orbea, H., Diggelmann, H., Locksley, R. M., MacDonald, H. R. and Louis, J. A., IL-4 rapidly produced by Vβ4Vα8 CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice. Immunity 1997. 6: 541-549.
35. Ho, I. C., Hodge, M. R., Rooney, J. W. and Glimcher, L. H., The proto-oncogene c-maf is responsible for tissuespecific expression of interleukin-4. Cell 1996. 85: 973-983.
36. Saha, B., Harlan, D. M., Lee, K. P., June, C. H. and Abe, R., Protection against lethal toxic shock by targeted disruption of the CD28 gene. J. Exp. Med. 1996. 183: 2675-2680.
37. Saha, B., Jaklic, B., Harlan, D. M., Gary, G. S., June, C. H. and Abe, R., Toxic shock syndrome toxin-1 induced death is prevented by CTLA4-Ig. J. Immunol. 1996. 157: 3869-3875.
38. Palmer, L. D., Saha, B., Hodes, R. J. and Abe, R., The role of CD28 costimulation in immune-mediated responses against mouse mammary tumor viruses. J. Immunol. 1996. 156: 2112-2118.